Why the study?
The study investigated the association between neutrophil percentage-to-albumin ratio and mortality risks in U.S. adults with diabetes or prediabetes.
Does a higher neutrophil percentage-to-albumin ratio (NPAR) predict increased all-cause and cardiovascular mortality in adults with diabetes or prediabetes?
Does a higher neutrophil percentage-to-albumin ratio (NPAR) predict increased all-cause and cardiovascular mortality in adults with diabetes or prediabetes?
Answers are grounded in this paper and cite their sources.
NPAR is a novel, easily calculated biomarker reflecting inflammatory-nutritional interplay that independently predicts all-cause and cardiovascular mortality in patients with dysglycemia.
This cohort study investigated the association between neutrophil percentage-to-albumin ratio (NPAR) and mortality risks in U.S. adults with diabetes or prediabetes using National Health and Nutrition Examination Survey (NHANES) data (1999-2018). Among 101,316 screened participants, 47,477 eligible individuals (7,171 diabetes; 15,175 prediabetes) were analyzed after exclusions for age < 20 years, pregnancy, and missing data. NPAR was calculated as neutrophil percentage divided by albumin (g/dL). Mortality outcomes were ascertained via linkage to the National Death Index through 2019. Weighted multivariable Cox models adjusted for sociodemographic, metabolic, and clinical covariates revealed a J-shaped relationship between NPAR and mortality. Over a median follow-up of 99.5 months (IQR: 58-142), the highest NPAR quartile (Q4) demonstrated significantly elevated all-cause mortality (HR 1.585, 95% CI 1.434-1.753) and cardiovascular mortality (HR 1.642, 95% CI 1.370-1.969) compared to Q1. Restricted cubic spline analysis identified an inflection point at NPAR = 1.399. Below this threshold, NPAR associated only with cardiovascular mortality (HR 1.871, 95% CI 1.249-2.804), while values above 1.399 markedly increased risks for both all-cause (HR 3.241, 95% CI 2.343-4.483) and cardiovascular mortality (HR 2.062, 95% CI 1.213-3.503). Subgroup analyses confirmed consistency across age, gender, BMI, and comorbidity strata. These findings position NPAR as a novel integrative biomarker reflecting inflammatory-nutritional interplay, with critical prognostic value for mortality risk stratification in dysglycemic populations.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: